论文部分内容阅读
目的:评价α1受体阻滞剂坦索罗辛在ESWL治疗输尿管结石中的辅助排石效果。方法:将符合条件的160例输尿管结石患者在ESWL治疗后随机分成两组,一组给予常规治疗作为对照,另一组(观察组)除给予常规治疗外,增加坦索罗辛0.4mg/d。结果:在观察时间内,对照组排石率(53%)明显低于观察组(74%),两组之间的差异有统计学意义(P<0.05)。结论:坦索罗辛能提高输尿管结石ESWL治疗后的排石率,可作为输尿管结石ESWL治疗后的辅助排石疗法。
OBJECTIVE: To evaluate the effect of tamsulosin, an α1-receptor blocker, on ESWL-assisted ureteral calculi. Methods: A total of 160 patients with ureteral calculi under ESWL were randomly divided into two groups. One group received routine treatment as control group, another group (observation group) received tamsulosin 0.4 mg / d . Results: During the observation time, the rate of stone removal in the control group (53%) was significantly lower than that in the observation group (74%). The difference between the two groups was statistically significant (P <0.05). Conclusion: Tamsulosin can improve the rate of stone extraction after ESWL treatment of ureteral calculi, which can be used as assistant stone therapy after ureteral stone ESWL treatment.